4//SEC Filing
FINKELSTEIN J J 4
Accession 0000914190-18-000281
CIK 0000707511other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:18 PM ET
Size
7.0 KB
Accession
0000914190-18-000281
Insider Transaction Report
Form 4
FINKELSTEIN J J
DirectorPresident and CEO
Transactions
- Conversion
Convertible Promissory Note (right to buy)
2018-07-05−104,456→ 0 totalExercise: $0.06From: 2013-07-05Exp: 2018-07-04→ Common Stock (104,456 underlying) - Conversion
Common Stock
2018-07-05$0.06/sh+104,456$6,267→ 1,637,991 total
Footnotes (1)
- [F1]The Convertible Promissory Note in the principal amount of $5,000 accrued $1,267.36 in interest and both principal and interest were converted into 104,456 shares of common stock at a conversion price of $0.06 per share.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001125610
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:18 PM ET
- Size
- 7.0 KB